Development of new plasmid DNA vaccine vectors with R1-based replicons
<p>Abstract</p> <p>Background</p> <p>There has been renewed interest in biopharmaceuticals based on plasmid DNA (pDNA) in recent years due to the approval of several veterinary DNA vaccines, on-going clinical trials of human pDNA-based therapies, and significant advance...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | Microbial Cell Factories |
Subjects: | |
Online Access: | http://www.microbialcellfactories.com/content/11/1/107 |